The insulin-like growth factor system in adrenocortical growth control and carcinogenesis

Adrenocortical Carcinoma: Basic Science and Clinical Concepts

Volumn , Issue , 2011, Pages 235-262

  Fottner, Christian ^a   Niederle, Ina M ^a   Weber, Matthias M ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865213391     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-77236-3_15     Document Type: Chapter

References (159)

1. Schutt BS et al (2004) Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 32:859-68
2. Baserga R (1995) The IGFIR: a key to tumor growth? Cancer Res 555:249-252
3. Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65:311-320
4. Samani AA et al (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47
5. Doerr ME, Jones JI (1996) The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem 271:2443-7
6. Khandwala HM et al (2000) The effects of insulin-like growth factors on tumourigenesis and neoplastic growth. Endocrine Reviews 21:215-244
7. Chitnis MM et al (2008) The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 14:6364-70
8. Pollak MN (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915-28
9. Mesiano S, Jaffe RB (1997) Development and functional biology of the primate fetal adrenal cortex. Endocr Rev 18:378-403
10. Penhoat A et al (1988) Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function. Endocrinology 122:2518-1526
11. Weber MM et al (1994) Identification and characterization of insulin-like growth factor I (IGF1) and IGF2/mannose-6-phosphate (IGF2R) receptors in bovine adrenocortical cells. Eur J Endocrinol 130:165-170
12. Penhoat A et al (1994) Regulation of adrenal cell-differentiated functions by growth factors. Horm Res 42:39-43
13. Mesiano S et al (1992) Mitogenic action, regulation and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 76:968-976
14. Han VK et al (1992) Insulin-like growth factor-II (IGF2) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: evidence of an autocrine/paracrine role for IGF2. Endocrinology 131:1300-1309
15. Voutilainen R, Miller WL (1987) Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues. Proc Natl Acad Sci USA 84:1590-1594
16. Mesiano S et al (1997) Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: Implications for adrenal androgen regulation. J Clin Endocrinol Metab 82:1390-1396
17. L'Allemand D et al (1996) Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab 81:3892-3897
18. Pham-Huu-Trung MT et al (1991) Effects of insulin-like growth factor-I (IGF1) on enzymatic activity in human adrenocortical cells. Interactions with ACTH. J Steroid Biochem Molec Biol 39:903-909
19. Glasscock GF et al (1992) Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat. Endocrinology 130:203-210
20. Rogler CE et al (1994) Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 260:13779-13784
21. Rainey WE et al (2002) The adrenal genetic puzzle: how do the fetal and adult pieces differ? Endocr Res 28:611-622
22. Wilson DM et al (1987) Transplantation of IGF2 secreting tumours in to nude rodents. Endocrinology 120:1896-1901
23. Ward A et al (1994) Disproportionate growth in mice with IGF2 transgenes. Proc Natl Acad Sci USA 91:10365-10369
24. Fottner C et al (1998) Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF1 and more potently IGF2 preferentially enhance androgen biosynthesis through interaction with the IGFIR and IGF-binding proteins. J Endocrinol 158:409-417
25. Fottner C et al (2007) The divergent effect of insulin-like growth factor binding protein (IGFBP-) 1 on the steroidogenic effect of IGF1 and IGF2 in bovine adrenocortical cells is not due to its phosphorylation status. Growth Hormone and IGF-Research 13:219
26. Miller WL (1999) The molecular basis of premature adrenarche: a hypothesis. Acta Pediatr Suppl 88:60-66
27. Baquedano MS et al (2005) Expression of the IGF System in Human Adrenal Tissues from Early Infancy to Late Puberty: Implications for the Development of Adrenarche. Pediatr Res 58:451-458
28. Kasayama S et al (2007) Independent association between insulin-like growth factor-I and dehydroepiandrosterone sulphate in women in middle adulthood. Clin Endocrinol 66:797-802
29. Barbieri RL et al (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62:904-910
30. Ross JT et al (2007) Intrafetal insulin-like growth factor-I infusion stimulates adrenal growth but not steroidogenesis in the sheep fetus during late gestation. Endocrinology 148:5424-5432
31. Han VK et al (1987) Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236:193-197
32. Ilvesmäki V et al (1993) Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF2 expression in functional ACCs. J Clin Endocrinol Metab 77:852-8
33. Kamio T et al (1991) Immunoreactivity and receptor expression of insulin-like growth factor I and insulin in human adrenal tumors. Am J Pathol 138:83-91
34. Shigematsu K et al (1989) Receptor autoradiographic localization of insulin-like growth factor-I (IGF1) binding sites in human fetal and adult adrenal glands. Life Sci 45:383-389
35. Pillion DJ et al (1988) Distribution of receptors for insulin and insulin-like growth factor I (somatomedin C) in the adrenal gland. Biochem Biophys Res Commun 154:138-145
36. Weber MM et al (1997) Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands. Eur J Endocrinol 136:296-303
37. Belgorosky A et al (2009) Expression of the IGF and the aromatase/estrogen receptor systems in human adrenal tissues from early infancy to late puberty: Implications for the development of adrenarche. Rev Endocr Metab Disord 10:51-61
38. Weber MM et al (1998) Adrenocortical and adrenomedullary cells, In: Bidey ES (ed) Endocrine cell culture, Cambridge University Press, Cambridge
39. Coulter CL (2005) Fetal adrenal development: insight gained from adrenal tumors, Trends in Endocrinology and Metabolism 16:235-242
40. Logie A et al (1999) Autocrine role of IGF2 in proliferation of human ACC NCL H295R cell line. J Mol Endocrinol 23:23-32
41. LeRoith D, Roberts Jr CT (2003) The Insulin-like growth factor system and cancer. Cancer letters 195:127-137
42. Fottner C et al (1999) Characterization of Insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: Regulation by Insulinlike growth factors (IGFs) and adrenocorticotropin (ACTH). Hormone and Metabolism Res 31:203-208
43. Fottner C et al (2001) Identification and characterization of Insulin-like growth factor binding protein-expression and - secretion by adult human adrenocortical cells: Differential regulation by IGFs and adrenocorticotropin. J Endocrinol 168:465-474
44. Grimberg A, Cohen P (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183:1-9
45. Weber MM et al (1995) Insulin-like growth factor II (IGF2) is more potent than IGF1 in stimulating cortisol secretion from cultured bovine adrenocortical cells: Interactions with the IGFIR and IGF-binding proteins. Endocrinology 136:3714-3720
46. Maile LA, Holly JM (1999) Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res 9:85-95
47. Miell JP et al (1997) Insulin-like growth factor binding protein concentration and post-translational modification in embryological fluid. Mol Hum Reprod 3:343-349
48. Conover CA, De Leon DD (1994) Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 269:7076-7080
49. Hoeflich A et al (2002) Insulin-like growth factor binding protein-2 (IGFBP-2) separates hypertrophic and hyperplastic effects of Growth Hormone (GH)/IGF1 excess on adrenocortical cells in vivo. FASEB-J 16:1721-1731
50. Hoeflich A et al (1999) Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140:5488-5496
51. Weber MM et al (1999) Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis. Endocrinology 140:1537-1543
52. Conlon MA et al (1995) Long R3 Insulin-like growth factor I (IGF1) infusion stimulates organ growth but reduces plasma IGF1, IGF2 and IGF binding protein concentrations in the guinea pig. J Endocrinol 146:247-253
53. Weber MM et al (2000) The role of the insulin-like growth factor (IGF) system in adrenocortical tumourigenesis. Eur J Clin Invest 30:69-75
54. Boulle N et al (2000) Fibroblast growth factor-2 inhibits the maturation of pro-insulin-like growth factor-II (Pro-IGF2) and the expression of insulin-like growth factor binding protein-2 (IGFBP-2) in the human adrenocortical tumor cell line NCI-H295R. Endocrinology 141:3127-3136
55. De Fraipont F et al (2002) Transcription profiling of benign and malignant adrenal tumors by cDNA macro-array analysis. Endocr Res 28:785-786
56. Edgren M et al (1997) Biological characteristics of ACC: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 ACCs. Anticancer Res 17:1303-1310
57. Schneid H et al (1992) Abnormalities of insulin-like growth factor (IGF1 and IGF2) genes in human tumor tissue. Growth Regulation 2:45-54
58. Boulle N et al (1998) Increased levels of insulin-like growth factor II (IGF2) and IGF-Binding Protein-2 are associated with malignancy in sporadic adrenocortical tumors. J Clin Endocrinol Metab 83:1713-1720
59. Gicquel C et al (1994) Rearrangements at the 11p15 locus and overexpression of insulinlike growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab 78:1444-1453
60. Gicquel C et al (1997) Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: Study on a series of 82 tumors. J Clin Endocrinol Metab 82:2559-2565
61. Gicquel C et al (2001) Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 61:6762-6767
62. Giordano TJ et al (2003) Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162:521-531
63. Erickson LA et al (2001) Pathological features and expression of insulin-like growth factor-2 in adrenocortical neoplasms. Endocr Pathol 12:429-435
64. Wilkin F et al (2000) Pediatric adrenocortical tumors: molecular events leading to Insulinlike growth factor II gene overexpression. J Clin Endocrinol Metab 85:2048-2056
65. Almeida MQ et al (2008) Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J Clin Endocrinol Metab 93:3524-3531
66. De Fraipont F et al (2005) Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab 90:1819-1829
67. West AN et al (2007) Gene expression profiling of childhood adrenocortical tumors. Cancer Res 67:600-608
68. Slater EP et al (2006) Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur J Endocrinol 154:587-598
69. De Reyniès A et al (2009) Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 27:1108-1115
70. Giordano TJ et al (2009) Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 15:668-676
71. Velázquez-Fernández D et al (2005) Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 138:1087-1094
72. Barlaskar FM et al (2009) Preclinical targeting of the type I insulin-like growth factor receptor in ACC. J Clin Endocrinol Metab 94:204-212
73. Leboulleux S et al (2001) Loss of heterozygosity at the mannose-6-phosphate/insulin-like growth factor II receptor locus: a frequent but late event in adrenocortical tumorigenesis. Eur J Endocrinol 144:163-168
74. Boulle N et al (2001) Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. Eur J Endocrinol 144:29-36
75. Faical S et al (1998) Immunodetection of Insulin-like growth factor I (IGF1) in normal and pathological adrenocortical tissue. Endocr Pathol 9:63-70
76. Gicquel C et al (1995) Recent advances in the pathogenesis of adrenocortical tumours. Eur J Endocrinol 133:133-144
77. Fernandez-Ranvier GG et al (2008) Identification of biomarkers of ACC using genomewide gene expression profiling. Arch Surg 143:841-846
78. Rosati R et al (2008) High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation. Cancer Genet Cytogenet 186:19-24
79. Assié G et al (2007) Prognostic Parameters of Metastatic ACC. J Clin Endocrinol Metab 92:148-154
80. De Souza AT et al (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet. 11:447-449
81. Hill D. Relative abundance and molecular size of immunoreactive insulin-like growth factors I and II in human fetal tissues (1990) Early Hum Dev 21:49-58
82. Mesiano S et al (1993) Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 76:968-976
83. Wolf E et al (1994) Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 135:1877-1886
84. Blackburn A et al (1997) Actions and interactions of growth hormone and insulinlike growth factor-II: body and organ growth of transgenic mice. Transgenic Res 6:213-222
85. van Buul-Offers SC et al (1995) Overexpression of human insulin-like growth factor-II in transgenic mice causes increased weight of the thymus. J Endocrinol 144:91-502
86. Zaina S et al (2003) Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology 144:2695-2703
87. Cecim M et al (1991) Elevated corticosterone levels in transgenic mice expressing human or bovine growth hormone genes. Neuroendocrinology 53:313-316
88. Wolf E et al (1998) What is the function of IGF2 in postnatal life? Answers from transgenic mouse models. Growth Horm IGF Res 8:185-193
89. Libé R, Bertherat J (2005) Molecular genetics of adrenocortical tumours, from familial to sporadic disease. Eur J Endocrinol 153:477-487
90. Liu J et al (1995) H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 80:492-496
91. Toretsky JA, Helman LJ (1996) Involvement of IGF2 in human cancer. J Endocrinol 149:367-372
92. Kirschner LS (2002) Signaling pathways in ACC. Ann N Y Acad Sci 58:222-239
93. Bourcigaux N et al (2000) High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors. J Clin Endocrinol Metab 85:322-330
94. Paquette J et al (1998) The INS 5' variable number of tandem repeats is associated with IGF2 expression in humans. J Biol Chem 273:14158-14164
95. Yano T et al (1989) Genetic changes in human ACCs. J Natl Cancer Inst 81:518-523
96. Schneid H et al (1993) Parental allele specific methylation of the human insulin-like growth factor-II gene and Beckwith Wiedemann syndrome. J Med Genet 30:353-362
97. Martinerie C et al (2001) Altered expression of novH is associated with human adrenocortical tumorigenesis. J Clin Endocrinol Metab 86:3929-3940
98. Thibout H et al (2003) Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system. J Clin Endocrinol Metab 88:327-336
99. Makos Wales B et al (1995) p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nat Med 1:570-582
100. Neuberg M et al (1997) The p53/IGF-1 receptor axis in the regulation of programmed cell death. Endocrine 7:107-9
101. Werner H, Le Roith D (2000) New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci. 57:932-42
102. Werner H et al (2000) Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab 71:315-20
103. Girnita L et al (2000) Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53:functional impact. Cancer Res 60:5278-5283
104. Werner H et al (1996) Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 93:8318-8323
105. Reincke M et al (1994) p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab 78:790-796
106. Hoeflich A et al (1996) Coordinate expression of insulin-like growth factor II (IGF2) and IGF2/mannose-6-phosphate receptor mRNA during differentiation of human colon carcinoma cells (caco-2). Eur J Endocrinol 135:49-59
107. Weber MM et al (2002) Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer 95:2086-2095
108. Rubin R, Baserga R (1995) Insulin-like growth factor I receptor. Its role in cell proliferation, apoptosis, and tumourigenicity. Lab Invest 73:311-331
109. Singleton JR et al (1996) Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res 56:4522-4529
110. Sullivan KA et al (1995) Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 147:1790-1798
111. Menouny M et al (1997) Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factorbeta and retinoic acid. Endocrinology 138:683-690
112. Gelato MC, Vassalotti J (1990) Insulin-like growth factor II: possible local growth factor in pheochromocytoma. J Clin Endocrinol and Metabol 7:1168-1174
113. Haselbacher GK et al (1987) Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. PNAS 84:1104-1106
114. Fottner C et al (2006) Overexpression of the insulin-like growth factor I receptor on human pheochromocytomas. J Mol Endocrinol 36:279-287
115. Holzenberger M et al (2003) IGFIR regulates lifespan and resistance to oxidative stress in mice. Nature 421:182-187
116. Lithgow G, Gill MS (2003) Cost-free longevity in mice? Nature 421:125-127
117. Dahmer MK et al (1989) Characterization of insulin-like growth factor-I receptors in PC12 pheochromocytoma cells and bovine adrenal medulla. J Neurochem 53:1036-1042
118. Dahmer MK, Perlman RL (1988) Insulin and insulin-like growth factors stimulate deoxyribonucleic acid synthesis in PC12 pheochromocytoma cells. Endocrinology 22:2109-2113
119. Nielsen FC, Gammeltoft S (1988) Insulin-like growth factors are mitogens for rat pheochromocytoma PC 12 cells. Biochem Biophys Res Commun 154:1018-1023
120. Forbes BE et al (2002) Characteristics of binding of insulin-like growth factor (IGF)-I and IGF2 analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur J Biochem 269:961-968
121. Foncea R et al (1997) Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem 272:19115-9124
122. Kulik G et al (1997) Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 17:1595-1606
123. O'Gorman DB et al (1999) Decreased insulin-like growth factor-II/mannose-6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. Cancer Res 59:5692-5694
124. Souza RF et al (1999) Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 18:4063-4068
125. Lau MM et al (1994) Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes and Development 8:2953-2963
126. Ludwig T et al (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Developmental Biology 177:517-535
127. Wang Z et al (1994) Regulation of embryonic growth and lysosomal targeting by the imprinted IGF 2/Mpr gene. Nature 372:464-467
128. Hankins GR et al (1996) M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12:2003-2009
129. Oates AJ et al (1998) The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat 47:269-281
130. Ozturk M (1999) Genetic aspects of hepatocellular carcinogenesis. Seminars in Liver Disease 19:235-242
131. Scott CD, Firth SM (2004) The role of the M6P/IGF2 receptor in cancer: tumor suppression or garbage disposal? Horm Metab Res 36, 261-71
132. Xu Y et al (1997) Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor. Oncogene 14:1041-1046
133. Ilvesmäki V et al (1992) Insulin-like growth factor binding proteins in the human adrenal gland. Mol Cell Endocrinol 97:71-79
134. Logie A et al (2000) Establishment and characterization of a human ACC xenograft model. Endocrinology 141:3165-3171
135. Baxter RC, Martin JL (1989) Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Research 1:49-68
136. Holly J, Perks C (2006) The role of Insulin-like growth factor binding proteins. Neuroendocrinology 83:154-160
137. Pollak MN (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-18
138. Pollak MN et al (2004) Insulin-like growth factors and cancer. Nat Rev Cancer 14:277-286
139. Hoeflich A et al (2001) Insulin-like growth factor binding protein 2 in tumorigenesis: protector or promoter? Cancer Res 61:8601-8610
140. Hoeflich A et al (2000) Overexpression of insulin-like growth factor-binding protein 2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res 60:834-838
141. Shi Z et al (2007) Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A. Growth Horm IGF Res 17:113-121
142. Engstrom W et al (1987) Expression of growth regulatory genes in primary human testicular neoplasms. Int J Androl 10:79-84
143. Cazals V et al (1994) Insulin-like growth factors, their binding proteins, and transforming growth factor-1 in oxidant-arrested lung alveolar epithelial cells. J Biol Chem 269:14111-14117
144. Wang D et al (1994) Insulin-like growth factor-binding protein-2: the effect of human chorionic gonadotropin on its gene regulation and protein secretion and its biological effects in rat Leydig cells. Mol Endocrinol 8:69-76
145. Becher OJ et al (2008) IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK. J Child Neurol 23:1205-1213
146. Besnard V et al (2001) Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. Biochem Biophys Acta 1538:47-58
147. Hoeflich A et al (2003) Increased activity of catalase in tumor cells overexpressing IGFBP-2. Horm Metab Res 35:816-821
148. Iliopoulos D et al (2009) MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling. Cancer Res 69:3278-3282
149. Stratakis CA (2009) New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors. Mol Cell Endocrinol 300:152-157
150. Miyamoto S et al (2007) Matrix metalloproteinase-7 triggers the matricrine action of insulinlike growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. Cancer Sci 98:685-91
151. Rorive S et al (2008) Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas. Glia 56:1679-1690
152. Cazals V et al (1999) Role for NF-KB in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim Biophys Acta 1448:349-362
153. Perks CM et al (2007) IGF2 and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene 26:5966-5972
154. Hwang PH et al (2005) PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF2 expression in gastric cancer cells. Exp Mol Med 37:391-398
155. Moorehead RA et al (2003) Insulin-like growth factor-II regulates PTEN expression in the mammary gland. J Biol Chem 278:50422-50427
156. Dunlap SM et al (2007) Insulin-like growth factor binding protein 2 promotes glioma development and progression. PNAS 104:11736-11741
157. Kang-Park S, Lee YI (2003) PTEN modulates insulin-like growth factor II (IGF2)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF2 expression in hepatoma cells. FEBS Lett 545:203-208
158. Martin JL, Baxter RC (2007) Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology 148:2532-41
159. Chakrabarty S, Kondratick L (2006) Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biol Ther 5:189-197